American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) . Washington, DC: APA.
Coryell, W., Endicott, J. & Winokur, G. (1992) Anxiety syndromes as epiphenomena of primary major depression: outcome and familial psychopathology. American Journal of Psychiatry, 149, 100–107.
Endicott, J., Nee, J., Harrison, W., et al (1993) Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacology Bulletin, 29, 321–326.
Feske, U., Frank, E., Mallinger, A. G., et al (2000) Anxiety as a correlate of response to the acute treatment of bipolar I disorder. American Journal of Psychiatry, 157, 956–962.
First, M. B., Spitzer, R. L., Gibbon, M., et al (1997) Structured Clinical Interview for DSM – IV Axis 1
Disorders – Clinician Version. Washington, DC: American Psychiatric Press.
Frank, E., Shear, M. K., Rucci, P., et al (2000) Influence of panic–agoraphobic spectrum symptoms on treatment response in patients with recurrent major depression. American Journal of Psychiatry, 157, 1101–1107.
Frank, E., Cyanowski, J. M., Rucci, P., et al (2002) Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar I disorder. Archives of General Psychiatry, 59, 905–911.
Gaynes, B. N., Magruder, K. M., Burns, B. J., et al (1999) Does a coexisting anxiety disorder predict persistence of depressive illness in primary care patients with major depression?
General Hospital Psychiatry, 21, 151–153.
Guy, W. (1976) Clinical global impressions. In ECDEU Assessment Manual for Psychopharmacology, revised. Rockville, MD: National Institute of Mental Health.
Henry, C., Van den Bulke, D., Bellivier, F., et al (2003) Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer. Journal of Clinical Psychiatry, 64, 331–335.
Kolodziej, M. E., Griffin, M. L., Najavits, L. M., et al (2005) Anxiety disorders among patients with co-occurring bipolar and substance use disorders. Drug and Alcohol Dependence, 80, 252–257.
Leon, A. C., Solomon, D. A., Mueller, T. I., et al (2000) A brief assessment of psychosocial functioning of subjects with bipolar I disorder: the LIFE-RIFT Longitudinal Interval Follow-up Evaluation – Range Impaired Functioning Tool. Journal of Nervous and Mental Disease, 188, 805–812.
MacKinnon, D. F., Zandi, P. P., Cooper, J., et al (2002) Comorbid bipolar disorder. American Journal of Psychiatry, 159, 30–35.
McElroy, S. L., Altshuler, L. L., Suppes, T., et al (2001) Axis 1 psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. American Journal of Psychiatry, 158, 420–426.
Montgomery, S. A. & Asberg, M. (1979) A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382–389.
Otto, M. W., Perlman, C. A., Wernicke, R., et al (2004) Posttraumatic stress disorder in patients with bipolar disorder: a review of prevalence, correlates, and treatment strategies. Bipolar Disorder, 6, 470–479.
Perugi, G., Akiskal, H. S., Ramacciotti, S., et al (1999) Depressive comorbidity of panic, social phobic, and obsessive compulsive disorders re-examined: is there a bipolar II connection?
Journal of Psychiatric Research, 33, 53–61.
Perugi, G., Akiskal, H. S., Toni, C., et al (2001) The temporal relationship between anxiety disorders and (hypo)mania: a retrospective examination of 63 panic, social phobic and obsessive–compulsive patients with comorbid bipolar disorder. Journal of Affective Disorders, 67, 199–206.
Rotondo, A., Mazzanti, C., Dell'Osso, L., et al (2002) Catechol o-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder. American Journal of Psychiatry, 159, 23–29.
Sachs, G. S. (1990) Use of clonazepam for bipolar affective disorder. Journal of Clinical Psychiatry, 51 (suppl): 31–34.
Sachs, G. S., Guille, C. & McMurrich, S. (2002) A clinical monitoring form for mood disorders. Bipolar Disorders, 4, 323–327.
Sachs, G., Thase, M. E., Otto, M. W., et al (2003) Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP–BD). Biological Psychiatry, 53, 1028–1042.
Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., et al (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I): the development and validation of a structured diagnostic psychiatric interview for DSM – IV and ICD-10. Journal of Clinical Psychiatry, 59, 22–33.
Simon, N. M., Otto, M. W., Weiss, R. D., et al (2004a) Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP–BD. Journal of Clinical Psychopharmacology, 24, 512–520.
Simon, N. M., Otto, M. W., Wisniewski, S. R., et al (2004b) Anxiety disorder comorbidity in bipolar disorder: data from the first 500 STEP–BD participants. American Journal of Psychiatry, 161, 2222–2229.
Sung, M., Erklanli, A., Angold, A., et al (2004) Effect of age at first substance use and psychiatric comorbidity on the development of substance use disorders. Drug and Alcohol Dependence, 75, 287–299.
Weiss, R. D., Ostacher, M., Otto, M. W., et al (2005) Does recovery from substance use disorder matter in patients with bipolar disorder?
Journal of Clinical Psychiatry, 66, 730–735.
Young, R. C., Biggs, J. T., Ziegler, V. E., et al (1978) A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry, 133, 429–435.